National, 9th February 2026: Kerala based Preventify, healthcare startup focused on delivering standardized, high-quality preventive and chronic care in Tier-2 and Tier-3 India, has raised ₹2 crore in a pre-seed funding round led by operator-led accelerator PedalStart. The round also saw participation from a strong group of strategic angel investors, including Viren Shetty (Narayana Health), Jatin Kakrani (Dezy), the founders of Supertails, the founders of Agrizy, and senior leaders from India’s healthcare ecosystem. The capital raised will be deployed to build Preventify’s first cluster of 10 clinics, expand its chronic and lifestyle disease management programs, and strengthen its technology, diagnostics, and pharmacy integration. The company aims to create a repeatable, capital-efficient model for delivering consistent healthcare outcomes across underserved semi-urban and smaller towns.

Founded with the mission of bringing branded, evidence-based healthcare closer to where people live, Preventify operates at the intersection of clinical protocols, technology, diagnostics, and long-term patient engagement. The startup currently operates three clinics in Kerala and has already served over 40,000 patients, demonstrating strong demand and trust in markets where access exists but care quality and consistency remain fragmented.

“Healthcare in Tier-2 and Tier-3 India is not a problem of access anymore-it’s a consistency and continuity problem,” said Nirmal NR, Co- Founder and CEO- Preventify. “Patients often have access to doctors, labs, and pharmacies, but the care journey is fragmented and episodic. Our focus is on building standardised, protocol-driven and affordable care models that manage patients over time, especially for chronic conditions. This funding allows us to strengthen our clinical teams, expand our clinic clusters, and invest in systems that deliver reliable outcomes at scale”.

Investors backing Preventify were drawn to the company’s focus on preventive and chronic care, particularly in Tier-2 and Tier-3 India, where non-communicable diseases such as diabetes, hypertension, and respiratory conditions are rising rapidly. Preventify’s asset-light, cluster-based expansion model and emphasis on longitudinal patient relationships position it to address structural gaps in India’s healthcare system while building sustainable unit economics.

Over the next 12–18 months, Preventify plans to scale its clinic footprint across Kerala, investing in experienced clinicians, nurses, care coordinators, and central medical teams. The company is also strengthening its protocol-driven care pathways, subscription-based outcome tracking systems, and integrated diagnostics and pharmacy workflows to ensure consistent care quality across locations.

“Preventify is addressing one of the most critical gaps in India’s healthcare system-standardised and affordable chronic care outside metro cities,” said Manas Pal & Aditya Darolia, Co-founder, PedalStart. “The team has shown strong execution discipline, early clinical traction, and a clear understanding of how to scale healthcare responsibly. Their cluster-based approach and focus on long-term patient outcomes align closely with how we believe sustainable healthcare businesses should be built, and we’re excited to support them as they scale”.

In parallel, Preventify is accelerating the development of subscription-based managed care programs for chronic conditions such as diabetes, hypertension, and long-term respiratory diseases. These programs follow a phygital model, combining in-clinic consultations with digital monitoring, structured follow-ups, lifestyle interventions, and continuous care coordination.

Beyond capital, PedalStart, the lead investor, is working closely with Preventify as an accelerator partner, supporting the team on growth strategy, operational discipline, and scalable expansion processes. This hands-on involvement is helping Preventify transition from early validation to structured, cluster-based growth.

Looking ahead, Preventify plans to use this phase to prove repeatable expansion, strong clinical governance, and scalable economics, positioning the company for a future institutional or early-VC round. The long-term vision is to build a trusted, category-defining healthcare brand for India’s next 500 million people-focused on affordability, continuity of care, and measurable health outcomes.